extremely overvalued. From what I remember this company hasn't started production yet... Total debt at the end of the next quarter will be an eye-watering $30 million. It sounds like a death sentence to me.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress